» Articles » PMID: 30676931

Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) Treatment Initiation and Engagement Among Patients with Opioid Use Disorder Across 7 Health Systems

Abstract

The prevalence of opioid use disorder (OUD) has increased rapidly in the United States and improving treatment access is critical. Among patients with OUD, we examined factors associated with the Healthcare Effectiveness Data and Information Set (HEDIS) performance measures of alcohol and other drug (AOD) treatment initiation and engagement. Electronic health record and claims data between October 1, 2014, and August 15, 2015, from 7 health systems were used to identify patients ( = 11,490) with a new index OUD diagnosis (no AOD diagnosis prior <60 days) based on International Classification of Diseases (ICD)-9 codes. Multivariable generalized linear models with a logit link clustered on health system were used to examine the associations of patient demographic and clinical characteristics, and department of index diagnosis, with HEDIS measures of treatment initiation and engagement. The prevalence of OUD among all AOD diagnoses varied across health systems, as did rates of AOD initiation (5.7%-21.6%) and engagement (7.6%-24.6%). Those diagnosed in the emergency department (adjusted odds ratio [aOR] = 1.58, 95% confidence interval [CI] = 1.27,1.97) or psychiatry/AOD treatment (aOR = 2.92, 95% CI = 2.47,3.46) were more likely to initiate treatment compared with primary care. Older patients were less likely to initiate (age 50-64 vs. age 18-29: aOR = 0.42, 95% CI = 0.35, 0.51; age 65+ vs. age 18-29: aOR = 0.34, 95% CI = 0.26, 0.43), as were women (aOR = 0.72, 95% CI = 0.62, 0.85). Patients diagnosed in psychiatry/AOD treatment (aOR = 2.67, 95% CI = 1.98, 3.60) compared with primary care were more likely to engage in treatment. Those identified in an inpatient setting (aOR = 0.19, 95% CI = 0.14, 0.27 vs. primary care), those with medical comorbidity (aOR = 0.70, 95% CI = 0.52, 0.95), and older patients (age 50-64 vs. 18-29: aOR = 0.64, 95% CI = 0.46, 0.88; age 65+ vs. 18-29: aOR = 0.36, 95% CI = 0.22, 0.57) were less likely to engage in treatment. Rates of initiation and engagement for OUD patients vary widely with noticeable room for improvement, particularly in this critical time of the opioid crisis. Targeting patient and system factors may improve health system performance, which is key to improving patient outcomes.

Citing Articles

A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures.

Goal O, Amanda I, Adams C, Grando M Ann Med. 2025; 57(1):2447413.

PMID: 39745202 PMC: 11703095. DOI: 10.1080/07853890.2024.2447413.


Understanding the role of financial capacity in the delivery of opioid use disorder treatment.

Guerrero E, Amaro H, Kong Y, Khachikian T, Marsh J BMC Health Serv Res. 2023; 23(1):166.

PMID: 36797752 PMC: 9933309. DOI: 10.1186/s12913-023-09179-z.


Data needs and models for the opioid epidemic.

Blanco C, Wall M, Olfson M Mol Psychiatry. 2021; 27(2):787-792.

PMID: 34716409 PMC: 8554508. DOI: 10.1038/s41380-021-01356-y.


Stability in a large drug treatment system: Examining the role of program size and performance on service discontinuation.

Guerrero E, Alibrahim A, Howard D, Wu S, DAunno T Int J Drug Policy. 2020; 86:102948.

PMID: 32977185 PMC: 7508010. DOI: 10.1016/j.drugpo.2020.102948.


Strengths and weaknesses of existing data sources to support research to address the opioids crisis.

Smart R, Kase C, Taylor E, Lumsden S, Smith S, Stein B Prev Med Rep. 2020; 17:101015.

PMID: 31993300 PMC: 6971390. DOI: 10.1016/j.pmedr.2019.101015.

References
1.
Yarborough B, Chi F, Green C, Hinman A, Mertens J, Beck A . Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018; 12(4):278-286. DOI: 10.1097/ADM.0000000000000399. View

2.
Ross T, Ng D, Brown J, Pardee R, Hornbrook M, Hart G . The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Wash DC). 2015; 2(1):1049. PMC: 4371424. DOI: 10.13063/2327-9214.1049. View

3.
DOnofrio G, Chawarski M, OConnor P, Pantalon M, Busch S, Owens P . Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention. J Gen Intern Med. 2017; 32(6):660-666. PMC: 5442013. DOI: 10.1007/s11606-017-3993-2. View

4.
ODonnell J, Halpin J, Mattson C, Goldberger B, Gladden R . Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(43):1197-1202. PMC: 5689219. DOI: 10.15585/mmwr.mm6643e1. View

5.
McCarty D, Priest K, Korthuis P . Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities. Annu Rev Public Health. 2017; 39:525-541. PMC: 5880741. DOI: 10.1146/annurev-publhealth-040617-013526. View